New findings on stigma, treatment of childhood obesity

October 30, 2001

The nation's foremost experts in childhood and adolescent obesity are presenting the latest findings on this growing epidemic during Obesity: The Public Health Conference, Nov. 8-9 at Washington's Georgetown University Conference Center. Presentations from physicians and other health officials from such prominent institutions as Harvard, Stanford, CDC, NIH are making new presentations on the stigma, causes, prevention and treatment of childhood and adolescent obesity.

The prevalence of obesity for boys has tripled in 25 years and more than doubled for girls. Some 25 percent of children and adolescents are overweight, twice as many as 30 years ago. About 13 percent of children and 14 percent of adolescents are obese.

Obesity in children has been associated with such serious health conditions as asthma, type 2 diabetes, hypertension and heart disease. The Centers for Disease Control and Prevention reported this year that the death rate from heart disease has increased among young Americans, citing obesity as a probable cause.

Obesity: The Public Health Conference is a national conference for public health officials, policy leaders and physicians to hear about he latest developments in the causes, prevention and treatment of obesity, the second leading cause of preventable death in the U.S. The two-day conference is Nov. 8-9, 8:45 AM to 5:00 PM, at Georgetown University Conference Center, 3800 Reservoir Road in Washington.

The American Obesity Association, the conference's sponsor, is a non-profit organization founded in 1995 whose fundamental mission is to have obesity regarded as a disease of epidemic proportions.

Highlights of childhood and adolescent obesity presentations include:

Thursday, Nov. 8:

Causes of Childhood and Adolescent Obesity
Thomas Robinson, MD, Assistant Professor of Pediatrics, Stanford University
11:15 AM

Stigma and Childhood Obesity
Janet Latner, Department of Psychology, Rutgers University
11:40 AM

Intervention in Adolescents With Obesity
Steven Gortmaker, Ph.D., Senior Lecturer, Department of Health & Social
Behavior, Harvard University
12:00 PM

The Development of Eating Disorders and Obesity in Adolescents
Susan Yanovski, MD, Director, Obesity and Eating Disorders Program,
National Institute of Diabetes & Digestive & Kidney Diseases, NIH
2:30 PM

Reimbursement for Treatment of Children and Adolescents
Andrew M. Tershakovec, MD, Division of Gastroenterology and Nutrition,
The Children's Hospital of Philadelphia
2:50 PM

Parent-Child Interaction on Eating, Weight and Physical Activity
Karen Miller-Kovach, MBA, MS, RD, Chief Scientist & General Manager of
Research & Development, Weight Watchers International, Inc.
3:10 PM

Reducing the Risk of Obesity in Public School
Cathy Nonas, MS, RD, St. Luke's/Roosevelt Hospital Center
4:00 PM

Friday, Nov. 9:

Developments in Obesity Treatment for Children and Adults
A. Drugs and Dietary Supplements
Steven Heymsfield, MD, Deputy Director, St. Luke's/Roosevelt Hospital's
Obesity Research Center
B. Behavioral and Pharmacological Treatment of Adolescent Obesity
Robert Berkowitz, MD, Associate Professor of Psychiatry & Pediatrics,
University of Pennsylvania School of Medicine
9:20 AM

Developing an Agenda for Prevention & Treatment of Child & Adolescent
William Dietz, MD, Ph.D., Director, Centers for Disease Control's
Division of Nutrition and Physical Activity/National Center for Chronic
Disease Prevention and Health Promotion
10:00 AM

Allhealth Public Relations

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to